Atomoxetine-induced mydriasis

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 5, 2008, Pages 539-541

  Alhatem, Fadi J ^a   Decker, David H ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

ADOLESCENT; ANAMNESIS; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; LETTER; MYDRIASIS; NAUSEA; PATIENT MONITORING; RATING SCALE; SIDE EFFECT; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; MYDRIASIS; PROPYLAMINES;

EID: 54249137226     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0015     Document Type: Letter

References (14)

1. American Glaucoma Society: http://www.glaucomaweb.org/.
2. th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
3. Atomoxetine Prescribing Information: http://pi.lilly.com/us/strattera-pi. pdf/.
4. Corman SL, Fedutes BA, Culley CM: Atomoxetine: The first nonstimulant for the management of ADHD. Am J Health-Syst Pharm 61:2391-2399, 2004.
5. Elolia R, Strokes J: Monograph Series on Aging-related Diseases: XI Glaucoma. Chronic Dis Can 19, No.4, 2004.
6. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K., Spencer, T, Ustun TB, Walters EE, Zaslavsky AM: The prevalence and correlates of adult ADHD in the United States: Results From the National Comorbidity Survey Replication. Am J Psychiatry 163:716-723, 2006.
7. Khaw PT, Shah P, Elkington AR: Glaucoma-1: Diagnosis. BMJ 328:97-99, 2004.
8. Kleinstein RS: Vision disorders in public health. Annu Rev Public Health 5:369-384, 1984.
9. Kreuser S, Riley J, Kolbasa K, Keerl A, Yappa U, Khan A, Heimbach T, Brammer D, Beidler D: A novel method to analyze atomoxetine-induced mydriasis in Sprague Dawley rats. J AALAM 45, No. 4 (Abstract), 2006.
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245, 1981.
11. Rappley MD: Attention-deficit/hyperactivity disorder. N Engl J Med 352:165-173, 2005.
12. Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, Robertson D, Biaggioni I: Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension 50:47-53, 2007.
13. Stein MT: Atomoxetine. Journal Watch Pediatrics and Adolescent, January16, 2004.
14. Wolfs RC, Grobbee DE, Hofman A, Jong PT: Risk of acute angle-closure glaucoma after diagnostic mydriasis in non-selected subjects: The Rotterdam Study. Invest Ophthalmol 38:2683-2687, 1997.